Jenny Robertson, Chief Legal Officer at Lexeo Therapeutics, Inc. (LXEO), sold 549 shares at $9.27 ($5K) on 2025-11-18, disclosed to the SEC on 2025-11-20.
Open-market sale of $5k LXEO by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LXEO | SELL | 2025-05-20 | $1K | — | Filing → |
| LXEO | SELL | 2025-02-21 | $9K | — | Filing → |